EUVIMEDEUVIMED entdecken
Open Access · CC0

Targeting of interaction between BB0323-BB0238 informs new paradigms in Lyme disease therapeutics

Sandhya Bista, Kalvis Brangulis, Bibek Bhattachan, Shelby D Foor, Michael H Ronzetti, Sankalp Jain, Jenna Miller, Jothy Lachumy Subramanion, Chrysoula Kitsou, Vipin S Rana, Ganesha Rai, Alexey V Zakharov und 3 weitere

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1013805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Sandhya Bista und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America. Hauptthemen laut MEDLINE: Lyme Disease, Borrelia burgdorferi, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, Intramural NIH HHS, Steven and Alexandra Cohen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Borrelia burgdorferi , one of the most prevalent tick-borne pathogens, can cause a complex and multisystem illness called Lyme disease, where there has been an unmet need for novel therapeutic or preventive strategies. We previously identified an essential protein-protein interaction (PPI) event in B. burgdorferi involving two unique proteins, BB0323 and BB0238; herein, we show that this PPI is indispensable for long-term borrelial survival in mammals and explore its potential as a novel target for small molecule therapeutics. Using X-ray crystallography, we solved the structure of the BB0238-BB0323 complex and identified the hotspot residues that form the biomolecular PPI interface area of ~1000 square Ångstroms. We then performed quantitative high-throughput drug screens of 62,740 diverse small molecules utilizing an amplified luminescent proximity homogeneous assay linked immunosorbent assay (AlphaLISA). Following a comprehensive pipeline to confirm small molecule hits, we short-listed three distinct PPI inhibitors of BB0238-BB0323. One of these inhibitors, called lomibuvir (VX-222, VCH-222), displayed robust PPI inhibition inside B. burgdorferi cells and was shown to affect pathogen persistence in a tick-borne murine model of Lyme disease. Our study highlights targeted PPI disruption as a new therapeutic strategy against B. burgdorferi and may foster future antimicrobial discovery efforts to resolve clinical complications associated with Lyme disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseBorrelia burgdorferiAnti-Bacterial AgentsBacterial ProteinsAnimalsMiceHumansCrystallography, X-Ray

Substanzen

Anti-Bacterial AgentsBacterial Proteins

Autor:innen und Institutionen

  • Department of Veterinary Medicine, University of Maryland, College Park, Maryland, United States of America.
  • Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Department of Human Physiology and Biochemistry, Riga Stradins University, Riga, Latvia.
  • National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America.
  • Virginia-Maryland College of Veterinary Medicine, College Park, Maryland, United States of America.

ORCID-Profile: Utpal Pal

Förderung

  • NIAID NIH HHS
  • Intramural NIH HHS
  • Steven and Alexandra Cohen Foundation
  • National Institute of Allergy and Infectious Diseases
  • University of Maryland
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Bista, S., Brangulis, K., Bhattachan, B., Foor, S. D., Ronzetti, M. H., Jain, S., Miller, J., Subramanion, J. L., Kitsou, C., Rana, V. S., Rai, G., Zakharov, A. V., Simeonov, A., Baljinnyam, B., & Pal, U. (2026). Targeting of interaction between BB0323-BB0238 informs new paradigms in Lyme disease therapeutics. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013805

Vancouver

Bista S, Brangulis K, Bhattachan B, Foor SD, Ronzetti MH, Jain S, et al. Targeting of interaction between BB0323-BB0238 informs new paradigms in Lyme disease therapeutics. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013805

BibTeX
@article{Bista2026,
  author = {Bista, Sandhya and Brangulis, Kalvis and Bhattachan, Bibek and Foor, Shelby D and Ronzetti, Michael H and Jain, Sankalp and Miller, Jenna and Subramanion, Jothy Lachumy and Kitsou, Chrysoula and Rana, Vipin S and Rai, Ganesha and Zakharov, Alexey V and Simeonov, Anton and Baljinnyam, Bolormaa and Pal, Utpal},
  title = {Targeting of interaction between BB0323-BB0238 informs new paradigms in Lyme disease therapeutics},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1013805}
}
Kostenlos starten →